Tramadol is not an NSAID. It is a synthetic opioid-type painkiller that works through completely different mechanisms than drugs like ibuprofen, naproxen, or aspirin. The confusion is understandable: both tramadol and NSAIDs are widely prescribed for many of the same conditions, and tramadol is sometimes presented as a “milder” alternative to stronger opioids, which can make it seem like it belongs in the same category as over-the-counter anti-inflammatory drugs. But the two classes of medication differ in how they reduce pain, what side effects they carry, and what conditions they are best suited for.
How NSAIDs Work
NSAIDs reduce pain by blocking enzymes called cyclooxygenases, specifically COX-1 and COX-2, which your body uses to produce prostaglandins. Prostaglandins are chemical messengers that drive inflammation, swelling, and the sensitization of nerve endings that makes injured tissue hurt. By slowing prostaglandin production, NSAIDs tackle pain at the site of tissue damage itself. This is why they are effective against conditions where inflammation is the core problem: arthritis flares, sprains, dental pain, menstrual cramps.1PubMed. The mechanisms of action of NSAIDs in analgesia
The distinction between COX-1 and COX-2 matters because COX-1 also protects the stomach lining and supports kidney function. Traditional NSAIDs like ibuprofen and naproxen inhibit both enzymes, which is why stomach ulcers and kidney problems are their best-known risks. Selective COX-2 inhibitors like celecoxib were developed to spare COX-1, reducing gut side effects while still fighting inflammation.2PubMed Central. An evidence-based update on nonsteroidal anti-inflammatory drugs NSAIDs also interfere with platelet function, which is why aspirin doubles as a blood thinner and why your surgeon tells you to stop taking ibuprofen before an operation.
How Tramadol Works
Tramadol is a synthetic analogue of codeine that acts inside the central nervous system rather than at the site of injury. It does two things at once: it binds to mu-opioid receptors in the brain and spinal cord, and it blocks the reuptake of serotonin and norepinephrine, two neurotransmitters involved in the body’s natural pain-dampening pathways.3American Journal of Health-System Pharmacy. Tramadol: A new centrally acting analgesic This dual action is unusual. Most opioids work only on opioid receptors, and most antidepressants work only on monoamine reuptake. Tramadol does both, though it does neither as powerfully as a dedicated drug in either category.4PubMed. What is the main mechanism of tramadol?
One thing tramadol does not do is block prostaglandin production. Researchers tested this directly and found that tramadol and its mirror-image forms did not inhibit the formation of prostaglandins. Whatever mild anti-inflammatory effect tramadol shows in some experimental setups, it is not happening through the COX pathway that defines NSAIDs.5PubMed. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxide synthases This is the most fundamental reason tramadol is not classified as an NSAID: it does not do the thing that makes an NSAID an NSAID.
Why Genetics Affect Tramadol but Not Ibuprofen
Tramadol is what pharmacologists call a prodrug. The tramadol molecule you swallow is not the main source of its opioid painkilling effect. Your liver has to convert it into an active metabolite called O-desmethyltramadol (usually just called M1), and that conversion is handled by a liver enzyme called CYP2D6.6PubMed Central. Population pharmacokinetic analysis of tramadol and O-desmethyltramadol with genetic polymorphism of CYP2D6 The M1 metabolite is the one that binds strongly to mu-opioid receptors.
This creates a problem: people inherit different versions of the CYP2D6 gene, and those versions differ enormously in how active the enzyme is. Roughly 5 to 10 percent of people of European descent are “poor metabolizers” who produce very little M1, meaning tramadol gives them barely any opioid-type pain relief. At the other extreme, “ultra-rapid metabolizers” convert tramadol to M1 so quickly that they can experience an unexpectedly strong opioid effect, including dangerous respiratory depression. NSAIDs do not have this issue. Their mechanism does not depend on being converted to an active form by a genetically variable enzyme, so the dose-response relationship is far more predictable from person to person.
Head-to-Head Effectiveness
If you assumed tramadol, being an opioid-class drug, would be a stronger painkiller than an NSAID, you would be wrong in many common scenarios. A review published in Canadian Family Physician compared tramadol (with or without acetaminophen) against NSAIDs and found that patients taking tramadol were less likely to achieve a meaningful reduction in pain. NSAIDs had roughly an 18 percent advantage in the proportion of patients reaching at least a 30 percent drop in pain scores. At the same time, tramadol was nearly three times more likely to cause side effects severe enough to make patients quit the study.7PubMed Central. Tramadol (with or without acetaminophen) efficacy and harm
This finding surprises people because they associate “opioid” with “stronger.” Tramadol’s opioid activity is weak compared to drugs like morphine or oxycodone. Where tramadol can be useful is in pain that involves nerve-related components, not just tissue inflammation. NSAIDs are excellent for inflammatory pain but have shown limited effect in models of neuropathic pain, while tramadol’s dual mechanism appears to address both types.8Therapeutics and Clinical Risk Management. The role of tramadol in current treatment strategies for musculoskeletal pain In a rat study comparing the two drug types, tramadol and morphine reduced neuropathic pain while indomethacin (an NSAID) and acetaminophen did not.9PubMed. Acetaminophen and non-steroidal anti-inflammatory drugs interact with morphine and tramadol analgesia for the treatment of neuropathic pain in rats
Combining Tramadol and NSAIDs
Because the two drugs work through entirely different pathways, they can be used together, and sometimes this combination outperforms either alone. A clinical study of patients with acute low back pain compared NSAIDs alone against low-dose tramadol combined with an NSAID. At two months, pain scores were significantly lower in the combination group. The researchers argued that low back pain often starts as inflammatory but shifts toward nerve-related mechanisms over time, and NSAIDs alone may not keep up with that transition. Adding tramadol appeared to prevent the shift to chronic pain.10PubMed Central. Low-Dose Tramadol and Non-Steroidal Anti-Inflammatory Drug Combination Therapy Prevents the Transition to Chronic Low Back Pain
The same principle has shown up in veterinary medicine. In dogs with osteoarthritis, combining a reduced dose of the NSAID ketoprofen with tramadol provided longer-lasting pain relief than the NSAID alone; dogs in the combination group needed less rescue pain medication in the months following treatment.11PubMed Central. Safety and efficacy of reduced dosage ketoprofen with or without tramadol for long-term treatment of osteoarthritis in dogs: a randomized clinical trial The concept is the same across species: attacking pain from two angles can be more effective than pushing one mechanism harder.
Side Effects Compared
The side effect profiles of tramadol and NSAIDs barely overlap, which is another sign of how different the drugs are.
NSAIDs are tough on the stomach and kidneys. Long-term use can cause gastric ulcers, intestinal bleeding, and reduced kidney function, especially in older adults or people who are dehydrated. They also carry cardiovascular risks: most NSAIDs (except low-dose aspirin and, to a lesser extent, naproxen) are associated with a modest increase in heart attack and stroke risk with prolonged use. And because they interfere with platelet aggregation, NSAIDs increase bleeding risk in surgical settings.
Tramadol’s side effects lean toward the neurological. Nausea, dizziness, constipation, and drowsiness are the most common complaints. The more serious risks are seizures and serotonin syndrome, a potentially dangerous condition caused by excess serotonin activity. Both of these are uncommon during normal use but become much more likely during overdose or when tramadol is combined with antidepressants or other serotonin-boosting drugs.12PubMed Central. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants The risk of these adverse events is modest in the general population, but outcomes can be severe if they are not recognized quickly.13PubMed. Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures
A recent study of older nursing home residents found that the seizure risk climbed further when tramadol was taken alongside antidepressants that inhibit the CYP2D6 enzyme, the same enzyme involved in tramadol metabolism. Blocking that enzyme changes how tramadol is processed and increases the buildup of compounds that lower the seizure threshold.14PubMed Central. Risk of Seizure Associated With Concomitant Use of Tramadol and Antidepressants in Older Nursing Home Residents
Addiction Potential and Scheduling
Tramadol’s regulatory story reflects how long it took authorities to take its opioid identity seriously. It was available for years in the United States without being classified as a controlled substance at all. That changed in August 2014, when tramadol was placed on Schedule IV at the federal level, a designation it shares with drugs like benzodiazepines, indicating recognized but relatively low abuse potential compared to Schedule II opioids like oxycodone.15PubMed. The Risk of Chronic Opioid Utilization with Tramadol: A Narrative Review of the Literature
Research on actual abuse rates supports the Schedule IV designation. In a 12-month study of patients with chronic pain, roughly 2.7 percent of tramadol users showed signs of abuse or dependence, compared to 2.5 percent for NSAIDs and 4.9 percent for hydrocodone. When researchers looked for persistent patterns of abuse rather than a single episode, the rates dropped to 0.7 percent for tramadol and 0.5 percent for NSAIDs, with both being significantly lower than hydrocodone.16PubMed. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain German safety databases calculated the incidence of tramadol abuse or dependency at extremely low rates per million daily doses, and noted that rates had been declining over time.17PubMed. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany
That said, “low relative to stronger opioids” is not the same as “zero.” Tramadol withdrawal is real, dependence develops with regular use, and the drug’s years of uncontrolled status likely contributed to overprescribing. NSAIDs carry no meaningful addiction risk, which is one of the clearest practical distinctions between the two drug classes.
Heart Attack Risk and a Counterintuitive Finding
One of the more surprising recent findings in this space is that tramadol may not be the heart-friendly alternative to NSAIDs that some prescribers assumed. A large study of osteoarthritis patients found that those starting tramadol had a higher rate of heart attacks than those starting naproxen, with roughly 4.8 events per 1,000 person-years for tramadol versus 2.8 for naproxen. The comparison with diclofenac was less clear, with overlapping confidence intervals suggesting no definitive difference.18PubMed Central. Association of Tramadol with Risk of Myocardial Infarction Among Patients with Osteoarthritis
A separate population-based study looking at cardiovascular disease more broadly found no significant difference between tramadol and NSAIDs.19PubMed Central. Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study The picture is not yet settled, but the old assumption that switching a patient from an NSAID to tramadol automatically makes their heart safer has not held up under scrutiny. Prescribers who make that switch to protect the cardiovascular system should weigh the data rather than relying on intuition about drug classes.
Tramadol and Fracture Risk in Older Adults
Tramadol’s central nervous system effects create a risk that NSAIDs do not share: falls and fractures. Dizziness and sedation are common tramadol side effects, and in older adults, these translate directly into fall risk. A large cohort study found that patients who started tramadol had higher rates of hip fracture than those who started naproxen, ibuprofen, celecoxib, or etoricoxib. The gap was substantial. Compared to naproxen, tramadol users had roughly 70 percent higher hip fracture rates; compared to celecoxib, the difference was closer to 85 percent.20Journal of Bone and Mineral Research. Association of Tramadol Use With Risk of Hip Fracture
Broader safety data in older osteoarthritis patients confirmed the pattern: tramadol users had higher risks of falls, fractures, emergency room visits, cardiovascular hospitalizations, and all-cause mortality (among new users) compared to people not on opioids at all. They fared better than users of stronger opioids, but not as well as those avoiding opioids entirely.21PubMed Central. Safety Events Associated with Tramadol Use Among Older Adults with Osteoarthritis For older adults, this is a practical reason to prefer NSAIDs when the stomach and kidneys can tolerate them, or to use tramadol cautiously with awareness of the fall risk.
Common Misconceptions
Several widespread misunderstandings surround these two drug classes. The first is the question this article addresses: many people do believe tramadol is some kind of NSAID, partly because it is prescribed for the same conditions and partly because doctors sometimes present it as a “step up” from ibuprofen without clarifying that it operates through a completely different mechanism. If you are allergic to NSAIDs, tramadol is safe to take from that standpoint. Conversely, if you have been told to avoid opioids, being handed a tramadol prescription should give you pause.
Another misconception is that NSAIDs are harmless because they are available over the counter. Research has found that patients in rheumatology clinics often underestimate the risks of combining prescribed and over-the-counter NSAIDs. Taking prescription-strength naproxen from your doctor while also popping ibuprofen from the drugstore is doubling your COX inhibition, and with it the risk of stomach bleeding and kidney problems.22Wolters Kluwer / Journal of Clinical Rheumatology. What Do Patients in Rheumatologic Care Know About the Risks of NSAIDs?
A third misconception runs in the opposite direction: that tramadol is “not really an opioid” because it is weaker than morphine and was unscheduled for so long. It is an opioid. It produces physical dependence. It can cause respiratory depression, especially in ultra-rapid metabolizers or when combined with other sedating drugs. And its monoamine reuptake effects add risks, like serotonin syndrome, that stronger opioids do not carry. In some ways, tramadol’s mixed mechanism makes it trickier to use safely than a straightforward opioid, because clinicians have to watch for both opioid-type and serotonergic adverse events.
When Veterinarians Face the Same Choice
The tramadol-versus-NSAID question comes up constantly in veterinary practice too, particularly for dogs and cats with osteoarthritis. NSAIDs designed for veterinary use (meloxicam, carprofen, ketoprofen) are the standard first-line treatment, much as they are in humans. Tramadol gets added when NSAIDs alone are not controlling pain sufficiently, or when GI side effects limit NSAID dosing. The pharmacokinetics differ across species: dogs metabolize tramadol much faster than humans, and some veterinary researchers have questioned whether dogs even produce enough of the active M1 metabolite to get meaningful opioid-type pain relief at standard doses. Cats, on the other hand, appear to metabolize tramadol more slowly and may get a stronger effect from the same relative dose. The clinical trial of dogs with osteoarthritis that combined a reduced NSAID dose with tramadol found the combination provided better and longer-lasting pain relief than the NSAID alone, suggesting that even in species where tramadol’s opioid contribution is uncertain, its monoamine effects still add something useful.11PubMed Central. Safety and efficacy of reduced dosage ketoprofen with or without tramadol for long-term treatment of osteoarthritis in dogs: a randomized clinical trial
Choosing Between Them in Practice
The choice between tramadol and an NSAID is not about which one is “stronger.” It is about matching the drug’s mechanism to the type of pain, the patient’s other health conditions, and the risks each individual can afford to take. A few rules of thumb emerge from the evidence:
- Inflammatory pain: NSAIDs are generally more effective. Arthritis flares, sports injuries, dental procedures, and post-surgical inflammation all respond well to COX inhibition.
- Neuropathic or mixed pain: Tramadol’s dual mechanism gives it an edge when nerve-related pain is part of the picture, such as in certain chronic back pain syndromes or diabetic neuropathy.
- GI or kidney vulnerability: If you have a history of stomach ulcers, GI bleeding, or impaired kidney function, tramadol avoids the prostaglandin-related damage that NSAIDs cause. This is one of the main clinical reasons tramadol gets prescribed instead.
- Seizure history or serotonergic drugs: If you take antidepressants (especially SSRIs, SNRIs, or MAOIs) or have a history of seizures, tramadol’s seizure-lowering and serotonin-boosting properties make it riskier than an NSAID.
- Older adults: The fracture and fall data suggest caution with tramadol in this population. An NSAID with gastroprotection (a proton pump inhibitor, for example) may be safer overall than tramadol if there are no kidney or cardiovascular contraindications.
Neither drug is universally superior. The question is which set of trade-offs fits a given patient at a given time, and that is a conversation worth having explicitly with whoever is writing the prescription.